Even relevant studies, such as the retrospective review of 98 cases of histoplasmosis in TNF-α inhibitor users published by Vergidis et al in 2015, the largest retrospective analysis of individual cases of this sort, lacked the necessary information regarding the source population required in our selection criteria for calculating the incidence rate.[19]. The gene discussed is TNF; the disease is histoplasmosis.